SF3B1 and breast carcinoma: Regarding expressions of SF3b complex components, it was reported that SF3B1 and SF3B3 are upregulated in fulvestrant/tamoxifen-resistant breast cancer cells, and SF3B3 overexpression associates with poor relapse-free and overall survival in ER-positive breast cancer patients [100].